PORTALUPPI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 25.184
AS - Asia 12.999
EU - Europa 7.388
SA - Sud America 2.108
AF - Africa 278
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 12
Totale 48.005
Nazione #
US - Stati Uniti d'America 24.774
SG - Singapore 4.881
CN - Cina 3.223
UA - Ucraina 1.704
BR - Brasile 1.608
IT - Italia 1.413
HK - Hong Kong 1.296
DE - Germania 1.278
VN - Vietnam 1.261
TR - Turchia 1.058
GB - Regno Unito 752
FI - Finlandia 546
FR - Francia 433
SE - Svezia 416
RU - Federazione Russa 401
JP - Giappone 270
IN - India 254
MX - Messico 211
AR - Argentina 175
BD - Bangladesh 151
CA - Canada 129
ID - Indonesia 89
ZA - Sudafrica 82
NL - Olanda 79
EC - Ecuador 75
IQ - Iraq 75
PL - Polonia 70
PK - Pakistan 68
CO - Colombia 67
ES - Italia 65
VE - Venezuela 56
PH - Filippine 55
MA - Marocco 51
MY - Malesia 44
SA - Arabia Saudita 40
AT - Austria 37
PE - Perù 37
CL - Cile 33
AU - Australia 32
BE - Belgio 31
UZ - Uzbekistan 31
PY - Paraguay 30
TN - Tunisia 29
LT - Lituania 25
AE - Emirati Arabi Uniti 24
CZ - Repubblica Ceca 22
KE - Kenya 22
EG - Egitto 19
KR - Corea 17
LB - Libano 17
NG - Nigeria 17
NP - Nepal 15
CH - Svizzera 14
CR - Costa Rica 14
IE - Irlanda 14
IL - Israele 14
JO - Giordania 14
RO - Romania 13
TH - Thailandia 13
BH - Bahrain 12
OM - Oman 12
BO - Bolivia 11
UY - Uruguay 11
BG - Bulgaria 10
PS - Palestinian Territory 10
TT - Trinidad e Tobago 10
ET - Etiopia 8
JM - Giamaica 8
NO - Norvegia 8
AZ - Azerbaigian 7
DZ - Algeria 7
GE - Georgia 7
KZ - Kazakistan 7
PA - Panama 7
PT - Portogallo 7
TW - Taiwan 7
BY - Bielorussia 6
DO - Repubblica Dominicana 6
EU - Europa 6
GA - Gabon 6
GT - Guatemala 6
HU - Ungheria 6
RS - Serbia 6
SN - Senegal 6
AO - Angola 5
HN - Honduras 5
IR - Iran 5
LV - Lettonia 5
AL - Albania 4
HR - Croazia 4
KW - Kuwait 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
QA - Qatar 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
CI - Costa d'Avorio 3
CY - Cipro 3
GR - Grecia 3
KG - Kirghizistan 3
Totale 47.943
Città #
Singapore 3.176
Fairfield 2.739
Woodbridge 2.496
Ashburn 2.265
Jacksonville 1.841
Houston 1.790
Chandler 1.349
Hong Kong 1.278
Ann Arbor 1.186
Santa Clara 1.099
Seattle 1.063
Wilmington 966
San Jose 938
Cambridge 846
Beijing 728
Izmir 539
Nanjing 474
Ho Chi Minh City 420
Princeton 335
Hanoi 299
Lauterbourg 278
Los Angeles 271
Tokyo 255
San Diego 251
Dallas 243
Boardman 237
Munich 187
Carrara 176
New York 172
Helsinki 169
Milan 160
Shenyang 158
Mexico City 142
São Paulo 133
Hefei 131
Nanchang 119
Tianjin 115
Changsha 113
Falls Church 104
Ferrara 100
Hebei 94
San Mateo 93
Shanghai 87
London 86
Orem 79
Jinan 78
Jiaxing 76
Washington 74
Addison 68
Norwalk 67
Buffalo 66
Council Bluffs 62
Da Nang 62
Haiphong 59
Warsaw 58
Chicago 55
Redwood City 55
Moscow 50
Chennai 49
Mountain View 46
Toronto 44
Zhengzhou 44
Brooklyn 43
Johannesburg 43
Rio de Janeiro 42
Kunming 40
Rome 40
Turku 39
Belo Horizonte 38
San Francisco 38
The Dalles 38
Dearborn 37
Denver 36
Philadelphia 36
Baghdad 34
Frankfurt am Main 34
Montreal 34
Saint Petersburg 34
Stockholm 34
Quito 31
Amsterdam 30
Ningbo 30
Orange 30
Verona 30
Atlanta 29
Guangzhou 29
Boston 28
Hangzhou 26
Jakarta 26
Poplar 26
Brussels 25
Mumbai 25
Tappahannock 25
Auburn Hills 24
Curitiba 24
Hải Dương 24
Tashkent 24
Goiânia 23
Lima 23
Brasília 22
Totale 31.987
Nome #
Chronotherapy of blood pressure medications to improve management of hypertension and reduce vascular risk 365
Cronofarmacologia e cronoterapia dell'ipertensione arteriosa 296
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 293
Administration-time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension 249
Low molecular weight heparins and glomerular filtration rate: A report to be considered 248
Circadian pattern in occurrence of renal colic in an emergency department: analysis of patients' notes 247
Circadian profile of plasma calcitonin gene-related peptide in healthy man 239
Ambulatory Blood Pressure Monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults 238
Detection of urinary abnormalities in a community from northern Italy based on the World Kidney Day screening program 237
An improvement in digoxin bioavailability. Studies with soft gelatin capsules containing a solution of digoxin 225
Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity 223
Elevated NT-proBNP levels should be interpreted in elderly patients presenting with dyspnea 217
Abnormalities in chronic kidney disease of ambulatory blood pressure 24 h patterning and normalization by bedtime hypertension chronotherapy 217
Diurnal and twenty-four hour patterning of human diseases: Acute and chronic common and uncommon medical conditions 216
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension 215
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man 214
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 214
Diurnal and twenty-four hour patterning of human diseases: Cardiac, vascular, and respiratory diseases, conditions, and syndromes 213
The Fast Fourier Transform in the Analysis of the Normal Phonocardiogram 212
Estimation of renal function in patients with eating disorders 212
Consistent changes in the circadian rhythms of blood pressure and atrial natriuretic peptide in congestive heart failure 208
Cardiomechanical effect of k-strophanthoside administered to healthy volunteers by the rectal route 207
Circadian and circannual rhythmicity in the occurrence of subarachnoid hemorrhage 204
Cocaine and acute vascular diseases 204
Morning preference in onset of symptomatic third-degree atrio-ventricular heart block 204
Chronotherapy of hypertension 203
Out-of-hospital sudden death referring to an emergency department 202
Mechanism of influence of PR interval on loudness of first heart sound 202
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial 198
Regarding "The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions" 195
Chronobiologic aspects of ischemic coronary artery disease 195
Circadian rhythms of atrial natriuretic peptide, blood pressure and heart rate in normal subjects 191
ST segment monitoring as a predictor of reperfusion after blood transfusion in a patient with acute non-Q-wave myocardial infarction 191
Circadian rhythms in mouse blood coagulation 190
Circadian disruption: New clinical perspective of disease pathology and basis for chronotherapeutic intervention 190
Does placebo lower blood pressure in hypertensive patients? A noninvasive chronobiological study 188
Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects 188
Chronobiological aspects of pulmonary thromboembolism 188
Circadian variation in onset of acute cardiogenic pulmonary edema is independent of patients' features and underlying pathophysiological causes 187
Bioavailability of digoxin improved by pharmaceutical manufactoring process 187
Circadian rhythms and cardiovascular health 187
Evidence-based statin prescription for cardiovascular protection in renal impairment 186
Diagnosis of mitral valve diseases using indirect (esophageal) left atrial pulse 185
Atrial natriuretic peptide and circadian blood pressure regulation: clues from a chronobiological approach 185
Clinical features of cardio-renal syndrome in a cohort of consecutive patients admitted to an internal medicine ward 184
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes 183
Circadian rhythmicity in the occurrence of spontaneous acute dissection and rupture of thoracic aorta 183
2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM). 182
Antagonisti del recettore dell’Angiotensina II e scompenso cardiaco. Domande e risposte per il medico pratico 181
The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease 180
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design 179
Altered circadian rhythms of blood pressure and heart rate in non-hemodialysis chronic renal failure 179
Estimation of glomerular filtration rate and assessment of risk of stroke in an emergency setting 178
Biological Rhythms, Drug Delivery, and Chronotherapeutics 178
SEASONAL VARIATION IN THE RUPTURE OF ABDOMINAL AORTIC ANEURYSMS 176
Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure 176
Binding and functional parameters of A2A adenosine receptors in essential hypertensive patients before and after pharmacological treatment 176
The main heart sounds as vibrations of the cardiohemic system: old controversy and new facts 175
Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man 172
Atrial strain is the main determinant of release of atrial natriuretic peptide 171
Phonometric study of the human first heart sound 171
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) 171
Differences in blood pressure regulation of congestive heart failure, before and after treatment, correlate with changes in the circulating pattern of atrial natriuretic peptide 171
Circadian variation in the occurrence of fatal pulmonary embolism. Differences depending on sex and age 171
Risk factors for metabolic syndrome in stable Italian renal transplant patients 171
Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease 170
Antiossidanti, pro-ossidanti e valutazione della capacità antiossidante 170
Circadian rhythms and medical diseases: Does it matter when drugs are taken? 169
Circadian and cyclic environmental determinants of blood pressure patterning and implications for therapeutic interventions 169
Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension 168
Effect of dermorphin on behavior and hippocampal electrical activity in rabbits 167
Ergometric evaluation of the effects of enalapril maleate in normotensive patients with stable angina 166
Pulmonary hypertension in dialysis patients: a cross-sectional Italian study 166
Chronobiologic vs. sphygmomanometric assessment of hypertension in a hospital setting 165
Disturbi d'ansia in Medicina Interna 165
Risk factors for renal disease and urinary abnormalities in men and women: Data from the world kidney day in the province of Ferrara, Italy 165
Esophageal left atrial pulse in mitral valve prolapse 164
Twenty-four-hour pattern of angina pectoris, acute myocardial infarction and sudden cardiac death: role of blood pressure, heart rate and rate-pressure product circadian rhythms 164
Ethics and methods for biological rhythm research on animals and human beings 164
A2A adenosine receptors and chronic caffeine intake in human neutrophils 164
Seasonal variation in the occurrence of nontraumatic rupture of thoracic aorta 164
Chronobiological patterns of onset of acute cerebrovascular diseases 164
Circadian variation in the onset of acute critical limb ischemia 163
Loss of nocturnal blood pressure fall in patients with renal impairment 163
Diurnal blood pressure variation and hormonal correlates in fatal familial insomnia 162
Biological rhythms, medication safety, and women's health 162
Delta opioid receptor involvement in endocrine pathophysiology 162
Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension 162
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects 161
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects. 160
Typical chest pain and onset of acute myocardial infarction in a prospective cohort of emergency calls 160
Dissociated 24-hour patterns of somatotropin and prolactin in fatal familial insomnia 160
Influence of circadian rhythm on mortality after myocardial infarction: data from a prospective cohort of emergency calls 160
Ambulatory blood pressure monitoring: Application to clinical medicine and antihypertension medication trials 160
Seasonal variations in the rupture of abdominal aortic aneurysms 160
May allergic syndrome represent valid trigger for Tako-tsubo cardiomyopathy? A systematic review of reported cases. 159
Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation 159
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 159
Bedtime hypertension chronotherapy: concepts and patient outcomes 158
Are we overtreating hypertensive patients? Chronobiologic vs. sphygmomanometric evaluation of ambulatory antihypertensive therapy 157
Totale 18.874
Categoria #
all - tutte 200.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 9.209
Totale 209.725


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.199 0 0 0 0 0 0 0 0 0 475 506 218
2021/20223.476 118 427 342 140 143 129 193 206 120 270 395 993
2022/20233.148 362 100 121 395 489 522 83 309 419 20 201 127
2023/20241.232 181 227 76 50 88 92 45 86 16 23 48 300
2024/20255.546 232 149 433 138 728 555 210 421 805 634 728 513
2025/202614.610 1.323 705 1.542 2.166 2.165 1.112 1.682 842 1.517 1.556 0 0
Totale 48.229